Sigma net profit drops 10.5%

Sales revenue was “heavily impacted” this year by a decline in the sales of low-margin hep C medicines Sigma Healthcare has reported a difficult financial year, but says it will continue to reinvest in the business and reward shareholders. While reported earnings before interest and tax was up 3.4% to $83.7 million, underlying EBIT fell